Biomedical Engineering Reference
In-Depth Information
Itaka K, Ohba S, Miyata K, Kawaguchi H, Nakamura K, Takato T, Chung U, Kataoka K.
Bone
regeneration by regulated in vivo gene transfer using biocompatible polyplex nanomicelles
.
Molecular Therapy 2007;15(9):1655.
Jackson S, DeLuca N.
Relationship of herpes simplex virus genome configuration to productive
and persistent infections.
Proc Natl Acad Sci. 2003;100(13):7871.
Jane J, Dunford B, Kron A, Pittman D, Sasaki T, Li J, Li H, Alden T, Dayoub H, Hankins G,
Kallmes D, Helm G.
Ectopic osteogenesis using adenoviral bone morphogenetic protein
(BMP)-4 and BMP-6 gene transfer.
Mol Ther 2002;6(4):464-70.
Jin Q, Anusaksathien O, Webb S, Printz M, Giannobile W.
Engineering of tooth-supporting struc-
tures by delivery of PDGF gene therapy vectors
. Mol Ther 2004;9:519-526.
Kaihara S, Dessho K, Okubo Y, Sonobe J, Kawai M, IIzuka T.
Simple and effective osteoinductive
gene therapy by local injection of a bone morphogenetic protein-2-expressing recombinant
adenoviral vector and FK506 in rats.
Gene Therapy 2004;11:439-447.
Kaludov N, Brown K, Walters R, Zabner J.
Adeno-associated virus serotype 4 (AAV4) and AAV5
both require sialic acid binding for hemagglutination and efficient transduction but differ in
sialic acid linkage specificity
. J Virol. 2001;6884-6893.
Kang Q, Sun M, Cheng H, Peng Y, Montag A, Deyrup A, Jiang W, Luu H, Luo J, Szatkowski J,
Vanichakarn P, Park J, Li Y, Haydon R, He T.
Characterization of the distinct orthotopic bone
formting activity of 14 BMPs using recombinant adenovirus-mediated gene delivery
. Gene
Ther 2004;11(17):1312-20.
Kanerva A, Wang M, Bauerschmitz G, Lam J, Desmond R, Bhoola S, et al.
Gene transfer to ovar-
ian cancer versus normal tissues with fiber-modified adenoviruses.
Molecular therapy.
2002;5(6):695-704.
Kawai M, Maruyama H, Bessho K, Yamamoto H, Miyazaki J, Yamamoto T.
Simple strategy for
bone regeneration with a BMP-2/7 gene expression cassette vector.
Biochem Biophys Res
Commun 2009;390(3):1012-7.
Kay M, Glorioso J, Naldini L.
Viral vectors for gene therapy: The art of turning infectious agents
into vehicles of therapeutics.
Nat Med. 2001;7(1):33-40.
Kelkar S, Pfister K, Crystal R, Leopold P.
Cytoplasmic dynein mediates adenovirus binding to
microtubules.
J Virol. 2004;78(18):10122.
Keller M, Harbottle R, Perouzel E, Colin M, Shah I, Rahim A, et al.
Nuclear localisation sequence
templated nonviral gene delivery vectors: Investigation of intracellular trafficking events of
LMD and LD vector systems.
Chembiochem. 2003;4(4):286-98.
Kennedy M, Parks R.
Adenovirus virion stability and the viral genome: size matters.
Molecular
Therapy. 2009;17(10): 1664-1666.
Kishimoto K, Watanabe Y, Nakamura H, Kokubun S.
Ectopic bone formation by electroporatic
transfer of bone morphogenetic protein-4 gene.
Bone 2002;31(2):340-347.
Kodama T, Aoi A, Watanabe Y, Horie S, Kodama M, Li L, Chen R, Teramoto N, Morikawa H,
Mori S, Fukumoto M.
Evaluation of transfection efficiency in skeletal muscle using nano/
microbubbles and ultrasound.
Ultrasound Med Biol. 2010;36(7):1196-205.
Kong Y, Yang T, Geller A.
An efficient in vivo recombination cloning procedure for modifying and
combining HSV-1 cosmids.
J Virol Methods. 1999;80(2):129-36.
Krieg A.
CpG Motifs in bacterial DNA and their immune effects
. Annu Rev Immunol 2002;20:
709-760.
Kunath K, Merdan T, Hegener O, Haberlein H.
Integrin targeting using RGD-PEI conjugates for
in vitro gene transfer.
J Gene Med 2003;5:588-599.
Kurihara D, Akita H, Kudo A, Masuda T, Futaki S, Harashima H.
Effect of polyethyleneglycol
spacer on the binding properties of nuclear localization signal-modified liposomes to isolated
nucleus
. Biol Pharmacet. Bull. 2009;32(7):1303-6.
Laquerre S, Anderson D, Stolz D.
Recombinant herpes simplex virus type 1 engineered for tar-
geted binding to erythropoietin receptor-bearing cells
. J Virol. 1998:9683-9697.
Lewis P, Emerman M.
Passage through mitosis is required for oncoretroviruses but not for the
human immunodeficiency virus.
J Virol. 1994;68(1):510-516.
Search WWH ::
Custom Search